CATX Insider Trading Activity and SEC Form 4 Filings
CATX insider trading summary
Over the past 12 months, insiders at Perspective Therapeutics, Inc. (CATX) reported 10 sales worth $2.5M by 2 insiders and 2 open-market purchases worth $42K by 2 insiders on SEC Form 4. Net insider selling was $2.5M.
Latest CATX insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Lantheus Alpha Therapy, LLC | 10% Owner | Sell | $526K (167,149 @ $3.15) |
| Sep 4, 2026 | Lantheus Holdings, Inc. | 10% Owner | Sell | $526K (167,149 @ $3.15) |
| Sep 3, 2026 | Lantheus Alpha Therapy, LLC | 10% Owner | Sell | $251K (80,783 @ $3.11) |
| Sep 3, 2026 | Lantheus Holdings, Inc. | 10% Owner | Sell | $251K (80,783 @ $3.11) |
| Sep 2, 2026 | Lantheus Holdings, Inc. | 10% Owner | Sell | $131K (42,129 @ $3.11) |
| Sep 2, 2026 | Lantheus Alpha Therapy, LLC | 10% Owner | Sell | $131K (42,129 @ $3.11) |
| Sep 1, 2026 | Lantheus Alpha Therapy, LLC | 10% Owner | Sell | $112K (35,769 @ $3.12) |
| Sep 1, 2026 | Lantheus Holdings, Inc. | 10% Owner | Sell | $112K (35,769 @ $3.12) |
| Aug 31, 2026 | Lantheus Alpha Therapy, LLC | 10% Owner | Sell | $246K (78,145 @ $3.14) |
| Aug 31, 2026 | Lantheus Holdings, Inc. | 10% Owner | Sell | $246K (78,145 @ $3.14) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.